Deep reinforcement learning has gathered much attention recently. Impressive results were achieved in activities as diverse as autonomous driving, game playing, molecular recombination, and robotics. In all these fields, computer programs have taught themselves to solve difficult problems. They have learned to fly model helicopters and perform aerobatic manoeuvers such as loops and rolls. In some applications they have even become better than the best humans, such as in Atari, Go, poker and StarCraft. The way in which deep reinforcement learning explores complex environments reminds us of how children learn, by playfully trying out things, getting feedback, and trying again. The computer seems to truly possess aspects of human learning; this goes to the heart of the dream of artificial intelligence. The successes in research have not gone unnoticed by educators, and universities have started to offer courses on the subject. The aim of this book is to provide a comprehensive overview of the field of deep reinforcement learning. The book is written for graduate students of artificial intelligence, and for researchers and practitioners who wish to better understand deep reinforcement learning methods and their challenges. We assume an undergraduate-level of understanding of computer science and artificial intelligence; the programming language of this book is Python. We describe the foundations, the algorithms and the applications of deep reinforcement learning. We cover the established model-free and model-based methods that form the basis of the field. Developments go quickly, and we also cover advanced topics: deep multi-agent reinforcement learning, deep hierarchical reinforcement learning, and deep meta learning.

Torrey Smith, Co-Founder of Endiatx, is changing the reputation endoscopies have for being uncomfortable. At Endiatx, they are developing a pill-sized robot that you swallow, which will then livestream your digestive system for a doctor to view. Our interviewer Abate dives in. Torrey Smith Torrey Smith is the Co-Founder & CEO of Endiatx, a medical robotics company that manufactures tiny robotic pills capable of active movement inside the human stomach with control over internet protocol. Prior to launching Endiatx, he developed medical devices in the areas of endometrial ablation, atherectomy, therapeutic hypothermia, sleep apnea, and vascular closure. An aerospace engineer by training, he takes a keen interest in the deep tech sector and is a proud mentor of up-and-coming founders at the Founder Institute. He is also the principal founder of the international arts collective known as Sextant, and he has had his art featured in the Smithsonian. Abate De Mey: Welcome to the robo hub podcast. Super excited to have you on here. So Torrey, could you introduce yourself a little bit? Well, you know, I originally originally studied aerospace engineering because my goal was to build the future of science fiction that I had read about as a kid. I had some relatives you know, come down with some gnarly health conditions. I lost an aunt to a brain cancer. I became very passionate about the world of medical devices and maybe more importantly, just health and technology and how we can merge those. Because I, I think if you asked a 14 year old kid who reads science fiction, what they think the future of healthcare looks like, they would probably say, oh, it's going to be like nano robots. That would go in like an army of tiny machines and kill any tumor. And then if you ask a doctor, Hey, I've got a glioblastoma. The doctor's going to say, well, we're going to cut an incision over here. I'm going to cut out a piece of your skull and put it in a steel dish. Then I'm going to go in and do my best to remove some of this brain tumor. And we're going to put you back together. We're going to put you on drugs. You know, we'll put you on chemo and you know, in six to nine months, you're going to be dead. And my question is simple.

Artificial intelligence can enhance efficiency and productivity in financial services and is hence emerging as an important tool in the industry. It can reduce human errors and biases, along with improving the quality by spotting anomalies that cannot be picked up from current reporting methods. We caught up with Jayashree Mitra, the head of technology (end-user services), Asia Pacific, to understand more about AI and automation in this industry. She has 23 years of cross-industry experience, of which she has spent 20 years working in Financial Services Technology for Standard Chartered Bank and UBS. Jayashree Mitra: Throughout my childhood, I was always taught the virtues of self-reliance.

San Francisco: Tesla and SpaceX CEO Elon Musk in an interview with artificial intelligence researcher Lex Fridman shared advice for students, such as reading books, avoiding becoming a leader, and helping. When asked what advice he would give to young people who want to do something big, Musk simply responded by saying "try to be useful".Also Read - Maybe I'm Partly Chinese: Elon Musk Reacts to Viral Video of His Asian Doppelganger Musk mentioned that the young generation should do things that are useful to fellow human beings and to the world. "It's very hard to be useful," Musk stated, urging young people to "contribute more than you consume". He also advised students to read and develop their general knowledge so they know what's going on around the world. Musk also noted that the more you talk to different kinds of people from all over the world, the more your mind will open.

Liz O'Sullivan is an expert in fair algorithms, surveillance, and artificial intelligence (AI) and the current CEO of AI company Parity.

'Gutfeld!' panel discusses the year in review as 2021 comes to a close. This is a rush transcript from "Gutfeld!," December 30, 2021. This copy may not be in its final form and may be updated. EMILY COMPAGNO, FOX NEWS CHANNEL HOST: I know what you're thinking. Greg's never looked at this good in a dress. Like a tiny Ghost of Christmas Present, because I'm celebrating the holiday today. Because this year COVID robbed me of Christmas with my family. COVID robbed us of our studio audience. And it robbed me of my Christmas Eve Feast of the Seven Fishes. So to make up for it, we are having a feast tonight. COMPAGNO: In New Year's Eve news, Omicron fear mongers are warning people to stay away from New York's Times Square celebration. Even though previous crowds were exposed to something much worse. Thank God it'll be me hosting in Time Square this year. See you at 10:00 p.m. Eastern on Fox News. Germany's also banned large group gatherings. But you know who's never bans large gatherings of Germans? China's Wuhan Institute of virology recently hosted a conference on lab safety, to which the world responded a little (BLEEP) late, guys. In a recent segment on COVID Safety, CNN's Dr. Leana Wen admitted cloth masks don't stop transmission of the virus. Today in New York Mayor Bill de Blasio said he doesn't believe in shutdowns despite having shut down the city for months. He then added "I also oppose letting criminals roam free to murder people." Chris Tucker turned down a $10 million payday for a sequel to the awesome movie Friday, saying he's too mature to be seen behaving badly on screen anymore.

'The Five' panel react to an Amazon Alexa instructing a child to stick a penny in an electrical outlet. This is a rush transcript from "The Five," December 30, 2021. This copy may not be in its final form and may be updated. It's five o'clock in New York City, and this is The Five. The White House desperately trying to clean up President Biden's COVID debacle. As America hits a record number of new cases, the commander-in- chief failing to live up to his promise to shut down the virus as people wait hours in lines while states struggle with testing shortages. The president still has not signed the contract to send Americans millions of at-home tests, and he is bragging about a new test making facility that won't even be ready until -- listen to this -- 2024. And so much for following the science, the CDC is now cutting isolation period for people with COVID in half. But not to make us safer. ANTHONY FAUCI, DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES: The reason is that now that we have such an overwhelming volume of cases coming in, many of which are without symptoms, there is the danger that this is going to have a really negative impact on our ability to really get society to function properly. So, the CDC made a decision to balance what is good for public health at the same time as keeping the society running. ROCHELLE WALENSKY, DIRECTOR, CENTERS FOR DISEASE CONTROL: It really had a lot to do with what we thought people would be able to tolerate. We really want to make sure that we have guidance in this moment where we were going to have a lot of disease that could be adhered to, that people were willing to adhere to and that spoke specifically to when people were maximally infectious. So, it really spoke to both behaviors as well as what people were able to do. MCENANY (on camera): President Biden is also being accused of sabotaging a key, life-saving treatment. Florida surgeon general claims the Biden administration has been, quote, "actively preventing monoclonal antibody treatments as states are running out of that therapeutic." Republicans are not happy about it. DAN CRENSHAW (R-TX): In Texas, we are one of those states that doesn't have these monoclonal antibodies anymore. We have been complaining to the administration about how these formulas are distributed.

Nine technologies developed at MIT Lincoln Laboratory have been selected as R&D 100 Award winners for 2021. Since 1963, this awards program has recognized the 100 most significant technologies transitioned to use or introduced into the marketplace over the past year. The winners are selected by an independent panel of expert judges. R&D World, an online publication that serves research scientists and engineers worldwide, announces the awards. The winning technologies are diverse in their applications.

DECEMBER 30, 2021 – Naval Surface Warfare Center, Crane Division (NSWC Crane), Office of Naval Research (ONR) and the NavalX Midwest Tech Bridge (MTB) recently announced the winners of the Artificial Intelligence for Small Unit Maneuvers (AISUM) Prize Challenge. EpiSys Science, Inc. (Episci) took first place and Draper, Inc. (Draper) took second place. According to their website, Episci is "a multidisciplinary innovation company that develops next-generation autonomous technologies for defense, aerospace, and commercial applications." Draper's website says the organization "serves our nation's interests and security needs; advances technologies at the intersection of government, academia, and industry; cultivates the next generation of innovators; and solves the most complex challenges." "The overall goal of this challenge was to move the technology needle," said Amy Ross, Program Manager for the AISUM Prize Challenge.

As 2021 draws to a close, we look back on some of the AI research, news, policy developments and awards that have piqued our interest. We start our round-up with awards, with many prestigious prizes being presented this year. Launched last year, the AAAI Squirrel AI Award recognises positive impacts of artificial intelligence to protect, enhance, and improve human life in meaningful ways with long-lived effects. The winner of the 2021 award was Cynthia Rudin for work in interpretable and transparent AI systems in real-world deployments. The 2021/2022 ACM Athena Lecturer Award went to Ayanna Howard, who was recognised for fundamental contributions to the development of accessible human-robotic systems and AI, and for her efforts to broaden participation in computing through entrepreneurial and mentoring.